Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multi-institutional experience of genetic diagnosis in Ecuador: National registry of chromosome alterations and polymorphisms.
Paz-Y-Miño C, Yumiceba V, Moreta G, Paredes R, Ruiz M, Ocampo L, Llamos Paneque A, Ochoa Pérez C, Ruiz-Cabezas JC, Álvarez Vidal J, Jiménez Torres I, Vargas-Vera R, Cruz F, Guapi N VH, Montalván M, Meneses Álvarez S, Garzón Castro M, Lamar Segura E, Recalde Báez MA, Naranjo ME, Tambaco Jijón N, Sinche M, Licuy P, Burgos R, Porras-Borja F, Echeverría-Garcés G, Pérez-Villa A, Armendáriz-Castillo I, García-Cárdenas JM, Guerrero S, Guevara-Ramírez P, López-Cortés A, Zambrano AK, Leone PE. Paz-Y-Miño C, et al. Among authors: burgos r. Mol Genet Genomic Med. 2020 Feb;8(2):e1087. doi: 10.1002/mgg3.1087. Epub 2019 Dec 12. Mol Genet Genomic Med. 2020. PMID: 31830383 Free PMC article.
The DeltaF508 mutation in Ecuador, South America.
Paz-y-Miño C, Pérez JC, Burgos R, Dávalos MV, Leone PE. Paz-y-Miño C, et al. Among authors: burgos r. Hum Mutat. 1999;14(4):348-50. doi: 10.1002/(SICI)1098-1004(199910)14:4<348::AID-HUMU11>3.0.CO;2-8. Hum Mutat. 1999. PMID: 10502783
Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDS.
Jang HJ, Urrutia G, Orskov AD, Kim HJ, Nelson SA, Nguyen AV, Lee H, Burgos RS, Johnson BK, Wegener M, Becker K, Adams M, Sheridan R, Ramjan ZH, Givan SA, Zebley CC, Youngblood BA, Issa JJ, Topper MJ, Baylin SB, Baer MR, Triche TJ, O'Connell CL, Gronbaek K, Jones PA. Jang HJ, et al. Among authors: burgos rs. bioRxiv [Preprint]. 2024 Nov 11:2024.11.08.622670. doi: 10.1101/2024.11.08.622670. bioRxiv. 2024. PMID: 39605731 Free PMC article. Preprint.
Development of a prognostic model to predict 90-day mortality in hospitalised cancer patients (PROMISE tool): a prospective observational study.
Mirallas O, Martin-Cullell B, Navarro V, Vega KS, Recuero-Borau J, Gómez-Puerto D, López-Valbuena D, Salva de Torres C, Andurell L, Pedrola A, Berché R, Palmas F, Ucha JM, Villacampa G, Rezqallah A, Sanz-Beltran J, Bach R, Bueno S, Viaplana C, Molina G, Hernando-Calvo A, Aguilar-Company J, Roca M, Muñoz-Couselo E, Martínez-Martí A, Alonso A, Eremiev S, Macarulla T, Oaknin A, Saura C, Élez E, Felip E, Peñuelas Á, Burgos R, Pardo PG, Garralda E, Tabernero J, Serradell S, Servitja S, Paez D, Dienstmann R, Carles J. Mirallas O, et al. Among authors: burgos r. Lancet Reg Health Eur. 2024 Oct 9;46:101063. doi: 10.1016/j.lanepe.2024.101063. eCollection 2024 Nov. Lancet Reg Health Eur. 2024. PMID: 39529819 Free PMC article.
Impact of a remdesivir formulary restriction by antimicrobial stewardship on drug utilization and cost at a safety-net community hospital during the COVID-19 pandemic.
Mena Lora AJ, Huber D, Li E, Lavani R, Ali M, Takhsh E, Burgos R. Mena Lora AJ, et al. Among authors: burgos r. Antimicrob Steward Healthc Epidemiol. 2024 Oct 7;4(1):e164. doi: 10.1017/ash.2024.438. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2024. PMID: 39417044 Free PMC article.
404 results